-
Je něco špatně v tomto záznamu ?
Efficacy of surfactant therapy of ARDS induced by hydrochloric acid aspiration followed by ventilator-induced lung injury - an animal study
P. Mikolka, P. Kosutova, M. Kolomaznik, S. Mateffy, N. Nemcova, D. Mokra, A. Calkovska
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- edém MeSH
- králíci MeSH
- kyselina chlorovodíková toxicita terapeutické užití MeSH
- plíce MeSH
- plicní surfaktanty * terapeutické užití farmakologie MeSH
- poškození plic mechanickou ventilací * farmakoterapie MeSH
- povrchově aktivní látky farmakologie terapeutické užití MeSH
- prasata MeSH
- syndrom dechové tísně * chemicky indukované farmakoterapie MeSH
- zánět MeSH
- zvířata MeSH
- Check Tag
- králíci MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The development of acute respiratory distress syndrome (ARDS) is known to be independently attributable to aspiration-induced lung injury. Mechanical ventilation as a high pressure/volume support to maintain sufficient oxygenation of a patient could initiate ventilator-induced lung injury (VILI) and thus contribute to lung damage. Although these phenomena are rare in the clinic, they could serve as the severe experimental model of alveolar-capillary membrane deterioration. Lung collapse, diffuse inflammation, alveolar epithelial and endothelial damage, leakage of fluid into the alveoli, and subsequent inactivation of pulmonary surfactant, leading to respiratory failure. Therefore, exogenous surfactant could be considered as a therapy to restore lung function in experimental ARDS. This study aimed to investigate the effect of modified porcine surfactant in animal model of severe ARDS (P/F ratio =13.3 kPa) induced by intratracheal instillation of hydrochloric acid (HCl, 3 ml/kg, pH 1.25) followed by VILI (V(T) 20 ml/kg). Adult rabbits were divided into three groups: untreated ARDS, model treated with a bolus of poractant alfa (Curosurf®, 2.5 ml/kg, 80 mg phospholipids/ml), and healthy ventilated animals (saline), which were oxygen-ventilated for an additional 4 h. The lung function parameters, histological appearance, degree of lung edema and levels of inflammatory and oxidative markers in plasma were evaluated. Whereas surfactant therapy with poractant alfa improved lung function, attenuated inflammation and lung edema, and partially regenerated significant changes in lung architecture compared to untreated controls. This study indicates a potential of exogenous surfactant preparation in the treatment of experimental ARDS.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23000919
- 003
- CZ-PrNML
- 005
- 20250422084114.0
- 007
- ta
- 008
- 230307s2022 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.935003 $2 doi
- 035 __
- $a (PubMed)36647912
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Mikolka, Pavol $u Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic $7 xx0233042
- 245 10
- $a Efficacy of surfactant therapy of ARDS induced by hydrochloric acid aspiration followed by ventilator-induced lung injury - an animal study / $c P. Mikolka, P. Kosutova, M. Kolomaznik, S. Mateffy, N. Nemcova, D. Mokra, A. Calkovska
- 520 9_
- $a The development of acute respiratory distress syndrome (ARDS) is known to be independently attributable to aspiration-induced lung injury. Mechanical ventilation as a high pressure/volume support to maintain sufficient oxygenation of a patient could initiate ventilator-induced lung injury (VILI) and thus contribute to lung damage. Although these phenomena are rare in the clinic, they could serve as the severe experimental model of alveolar-capillary membrane deterioration. Lung collapse, diffuse inflammation, alveolar epithelial and endothelial damage, leakage of fluid into the alveoli, and subsequent inactivation of pulmonary surfactant, leading to respiratory failure. Therefore, exogenous surfactant could be considered as a therapy to restore lung function in experimental ARDS. This study aimed to investigate the effect of modified porcine surfactant in animal model of severe ARDS (P/F ratio </=13.3 kPa) induced by intratracheal instillation of hydrochloric acid (HCl, 3 ml/kg, pH 1.25) followed by VILI (V(T) 20 ml/kg). Adult rabbits were divided into three groups: untreated ARDS, model treated with a bolus of poractant alfa (Curosurf®, 2.5 ml/kg, 80 mg phospholipids/ml), and healthy ventilated animals (saline), which were oxygen-ventilated for an additional 4 h. The lung function parameters, histological appearance, degree of lung edema and levels of inflammatory and oxidative markers in plasma were evaluated. Whereas surfactant therapy with poractant alfa improved lung function, attenuated inflammation and lung edema, and partially regenerated significant changes in lung architecture compared to untreated controls. This study indicates a potential of exogenous surfactant preparation in the treatment of experimental ARDS.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a králíci $7 D011817
- 650 12
- $a plicní surfaktanty $x terapeutické užití $x farmakologie $7 D011663
- 650 _2
- $a povrchově aktivní látky $x farmakologie $x terapeutické užití $7 D013501
- 650 _2
- $a kyselina chlorovodíková $x toxicita $x terapeutické užití $7 D006851
- 650 _2
- $a plíce $7 D008168
- 650 12
- $a syndrom dechové tísně $x chemicky indukované $x farmakoterapie $7 D012128
- 650 12
- $a poškození plic mechanickou ventilací $x farmakoterapie $7 D055397
- 650 _2
- $a zánět $7 D007249
- 650 _2
- $a edém $7 D004487
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kosutova, Petra $u Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic
- 700 1_
- $a Kolomazník, Maroš $7 xx0233029 $u Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic
- 700 1_
- $a Matéffy, Stanislav, $d 1987- $u Diagnostic Center of Pathology in Prešov, Unilabs Slovakia, Martin, Slovak Republic $7 xx0331345
- 700 1_
- $a Nemcova, Nikolett $u Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic
- 700 1_
- $a Mokrá, Daniela $7 xx0105806 $u Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic
- 700 1_
- $a Čalkovská, Andrea $7 mzk2004236811 $u Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, Suppl. 2 (2022), s. S237-S249
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36647912 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20230307 $b ABA008
- 991 __
- $a 20250422084116 $b ABA008
- 999 __
- $a ok $b bmc $g 1928840 $s 1187114
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 71 $c Suppl. 2 $d S237-S249 $e 202212031 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK198 $a Pubmed-20230307